Anju Ghangurde

Mahārāshtra

Executive Editor at Scrip

Executive Editor (Asia Pacific), Scrip/Pink Sheet, @Citeline @NorstellaCo but views own; believe in karma & that moms can move mountains

Featured in: Favicon

informa.com (+7) Favicon

lexisnexis.com Favicon

pharmamedtechbi.com Favicon

citeline.com (+1)

Articles

Big Top-Level Shifts At Sun: Ganorkar Is MD, Ex-Takeda Exec To Helm US Business

1 week ago | insights.citeline.com | Anju Ghangurde

Big Top-Level Shifts At Sun: Ganorkar Is MD, Ex-Takeda Exec To Helm US BusinessNorth America CEO to report to Sun scion Aalok ShanghviSun’s founder hands top job to company longtimer Kirti Ganorkar as the firm implements a “structured and forward-looking” succession plan, while Richard Ascroft will lead the Indian drugmaker’s North America business. Top management changes at Sun (Shutterstock)
Alzheimer’s Drug Leqembi May Be On Course To India, Kisunla In The Wings

1 week ago | insights.citeline.com | Anju Ghangurde

Alzheimer’s Drug Leqembi May Be On Course To India, Kisunla In The WingsKey expert panel go-ahead with a trial waiver put’s Eisai's Alzheimer's therapy on track for a debut in India where tailored pricing will be pivotal. Lilly’s Kisunla is also under regulatory review. Alzheimer's drugs on course to India? (Shutterstock)
Big Top-Level Shifts At Sun: Ganorkar Is MD, Ex-Takeda Exec To Helm US Business

2 weeks ago | insights.citeline.com | Anju Ghangurde

Big Top-Level Shifts At Sun: Ganorkar Is MD, Ex-Takeda Exec To Helm US BusinessSun’s founder hands top job to company longtimer Kirti Ganorkar as the firm implements a “structured and forward-looking” succession plan, while Richard Ascroft will lead the Indian drugmaker’s North America business. Top management changes at Sun (Shutterstock)
Pharma’s Space Trails Entering Transformative Era - Keytruda’s Been There

2 weeks ago | insights.citeline.com | Anju Ghangurde

Pharma’s Space Trails Entering Transformative Era - Keytruda’s Been ThereMerck and Lilly are among the leading pharma players using space-based research to power drug development. From reusable satellites to process drugs in low earth orbit to biomanufacturing labs experts discuss R&D opportunities in the starry canvas above. (Shutterstock/AI-generated)
Deal Build-Up Amid Early ‘Deep’ Response For IGI’s Trispecific In Myeloma

3 weeks ago | insights.citeline.com | Anju Ghangurde

Deal Build-Up Amid Early ‘Deep’ Response For IGI’s Trispecific In MyelomaIGI CEO tells Scrip about the “very encouraging” feedback at ASCO to promising early data for the firm's first-in-class investigational trispecific antibody in multiple myeloma. Is a licensing deal in the offing? Deal Chatter For IGI's early-stage MM asset (Shutterstock)
Public Health And Innovation: Addressing Gaps, Pharma’s Role

3 weeks ago | insights.citeline.com | Anju Ghangurde

Public Health And Innovation: Addressing Gaps, Pharma’s Role Expert panel including Ashok Venkitaraman, eminent clinician-scientist and Director of the Cancer Science Institute of Singapore, discuss public health challenges and innovations to address some of these. Long-acting drugs, intercepting cancer early were among the key talking points. Panelists discuss bridging the public health gap
Sun On Leqselvi US Launch Ahead, MFN Pricing And Pipeline Changes

1 month ago | insights.citeline.com | Anju Ghangurde

Sun On Leqselvi US Launch Ahead, MFN Pricing And Pipeline ChangesSun readies US debut of Leqselvi for alopecia areata, while PD-L1 inhibitor Unloxcyt is in the line up once the Checkpoint Therapeutics deal is completed. Management also discusses limited clarity on President Trump’s most favored nation pricing push, pipeline tweaks and M&A outlook. Sun readies at-risk launch (Shutterstock/AI-generated)
Pharma Women’s Workforce In India: Weak Start, Promotions, C-Suite Drop Off

1 month ago | insights.citeline.com | Anju Ghangurde

Pharma Women’s Workforce In India: Weak Start, Promotions, C-Suite Drop OffMcKinsey senior partner Vivek Pandit talks to Scrip about some of the intricacies underlying the key findings of a study on pharma’s workforce gender gap in India. Women’s representation starts low at entry level, peaks at senior manager positions and falls off again for C-suite roles, this found. Pharma's workforce gender gap in India (Shutterstock)
Lupin CEO On Trump’s Most Favored Nation Policy, Tariffs, Firm’s Five-Year Plan

1 month ago | insights.citeline.com | Anju Ghangurde

Lupin CEO On Trump’s Most Favored Nation Policy, Tariffs, Firm’s Five-Year PlanLupin CEO Vinita Gupta speaks on Trump’s most favored nation policy, the Inflation Reduction Act’s “pill penalty” and other developments in the US, a major market for the company. The company also outlines a five-year plan focused on complex generics and technology platforms. Lupin CEO Vinita Gupta and MD Nilesh Gupta At The Investor Meet (Citeline)
Asia Deal Watch: Lilly Partners With Rznomics On Hearing Loss

1 month ago | insights.citeline.com | Joseph Haas |Xu Hu |Anju Ghangurde |Lisa Takagi

Asia Deal Watch: Lilly Partners With Rznomics On Hearing LossPlus deals involving Minghui/Qilu, LENZ/Lotus, Amicus/Dimerix, Sanofi/Dr. Reddy’s, Henlius/Lotus, Apnimed/Desitin, Formosa/Saval, DAAN/GC Cell, VelaVigo/Ollin and Sol-Gel/Mayne.